HENRY SCHEIN INC (HSIC)
SEC filings, insider trading & institutional ownership from EDGAR.
Henry Schein, Inc., headquartered in Melville, New York, is a health care solutions company and, by its own assessment, the world's largest provider of health care products and services to office-based dental and medical practitioners and alternate sites of care. With 94 years of industry experience, the company serves more than one million customers worldwide, including dental practices, laboratories, physician practices, ambulatory surgery centers, and various institutional and home health care providers. The company employs over 25,000 people globally (approximately 48% in the U.S. and 52% internationally) and operates in 34 countries and territories, having grown through both organic expansion and strategic acquisitions.
Henry Schein stocks more than 300,000 branded and corporate-brand products, supported by an infrastructure of over 5.4 million square feet across 38 distribution centers and 0.6 million square feet across 17 manufacturing facilities worldwide, enabling efficient order fulfillment and positioning the company as a single-source supplier for its customers. The business operates through three reportable segments: Global Distribution and Value-Added Services, which distributes national and corporate-brand dental and medical merchandise, equipment, and technical services, along with value-added offerings such as financial services, continuing education, and practice consulting; Global Specialty Products, encompassing the manufacturing, marketing, and sale of dental implants, biomaterials, endodontic, orthodontic, and orthopedic products; and Global Technology, which develops and distributes practice management software and e-services for health care providers. The industry in which Henry Schein operates is fragmented, ranging from small independent practices to large dental support organizations and integrated delivery networks, and is characterized by frequent small-quantity orders requiring rapid, reliable fulfillment.
The company faces significant competition across its segments: in North American dental distribution, primary competitors include Patterson Dental and Benco Dental Supply Company; in U.S. medical distribution, main rivals are McKesson Corporation and Medline Industries; outside the U.S., competitors are largely regional and local dental distributors including Cadence Group, Proclinic Group, and Planmeca Group, among others. In Global Specialty Products, key competitors include Straumann, Envista, Zimvie, and Dentsply Sirona for implants, and Geistlich Pharma and Botiss Biomaterials in biomaterials. In Global Technology, competitors include Patterson's Eaglesoft, Carestream Dental, Open Dental Software, and Epic Systems, among others.
The company manufactures specialty products such as dental implants, endodontics, and orthopedics at its 17 manufacturing sites, while also outsourcing certain production, and sources raw materials from distributors and mills, maintaining what it believes is a readily available supply chain despite occasional reliance on single or limited suppliers.
AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.
Financials
As reported to the SEC via XBRL, no adjustments
| Gross profit | $4.11B |
| Operating income | $653.00M |
| Diluted EPS | $3.27 |
| Gross margin | 31.1% |
| Net margin | 3.2% |
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
| Form | Filed | Accession |
|---|---|---|
| 4Albertini Andrea | Sep 9, 2026 | 0002025230-26-000008EDGAR |
| SC 13GFMR LLC and 1 other reporting person | Aug 6, 2026 | 0000315066-26-002036EDGAR |
| 10-Q | Aug 4, 2026 | 0001000228-26-000045EDGAR |
| 8-K | Aug 4, 2026 | 0001000228-26-000043EDGAR |
| 8-K | Jul 30, 2026 | 0001193125-26-324857EDGAR |
| 4DANIEL WILLIAM K | Jun 15, 2026 | 0001190297-26-000004EDGAR |
| 4/ABERGMAN STANLEY M | May 26, 2026 | 0001193125-26-239640EDGAR |
| 4BERGMAN STANLEY M | May 22, 2026 | 0001193125-26-237318EDGAR |
Insider trading
From Form 4 filings
| Insider | Date | Type |
|---|---|---|
| Albertini Andrea | Sep 8, 2026 | Disposition |
| Albertini Andrea | Sep 8, 2026 | Tax withholding |
| DANIEL WILLIAM K | Jun 12, 2026 | Grant / award |
| BERGMAN STANLEY M | May 26, 2026 | Gift |
| BERGMAN STANLEY M | May 21, 2026 | Gift |
Top holders
13F & 13D/G · latest quarter
| Holder | Stake | Filed | Value |
|---|---|---|---|
| FMR LLC | 6.7% | Aug 13, 2026 | $630.90M |
| BlackRock, Inc. | 6.2% | Aug 7, 2026 | $586.70M |
| Vanguard Capital Management | 5.6% | Aug 13, 2026 | $530.07M |
| JPMORGAN CHASE & CO | 3.8% | Aug 12, 2026 | $366.43M |
| STATE STREET CORPORATION | 3.8% | Aug 7, 2026 | $359.58M |
HSIC's filings are public. The insight is one click away.
Scrutar's AI reads every HSIC filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a HSIC filing.
Get an email when HSIC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 16, 2026Source: SEC EDGAR.